Titre : | HIV/Hepatitis prevention in drug abuse treatment programs: guidance from research (2002) |
Titre traduit : | (Prévention du VIH et des hépatites au sein des programmes de traitements : recommandations issues de la recherche.) |
Auteurs : | J. L. SORENSEN ; C. L. MASSON ; D. C. PERLMAN |
Type de document : | Article : Périodique |
Dans : | Science and Practice Perspectives (Vol.1, n°1, July 2002) |
Article en page(s) : | 4-12 |
Note générale : |
Science and Practice Perspectives, 2002, 1, (1), 4-12 |
Langues: | Français |
Discipline : | MAL (Maladies infectieuses / Infectious diseases) |
Mots-clés : |
Thésaurus mots-clés VIH ; HEPATITE ; INFECTION ; DEPISTAGE ; REDUCTION DES RISQUES ET DES DOMMAGES ; PRISE EN CHARGE ; PROGRAMME |
Résumé : |
ENGLISH : A large body of research examines the relationship between HIV and drug dependence, but considerably less information is available on viral hepatitis and drug dependence. This article summarizes research indicating what drug abuse treatment programs can do to prevent their patients from acquiring HIV or hepatitis infection and to limit the consequences for patients who are already infected. Drug treatment programs can play a pivotal role in preventing, detecting, and treating HIV and hepatitis. Some activities can be accomplished by providers' simply becoming aware of the issues; others will require significant infusion of leadership, education, and fiscal support. (Author' s abstract) |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 19 |
Affiliation : |
Univ. of California, San Francisco Etats-Unis. United States. |
Numéro Toxibase : | 206483 |
Centre Emetteur : | 02 Coordonnateur |
Cote : | R00128 |
Accueil